Left atrial appendage occlusion for stroke prevention in atrial fibrillation: Multicentre experience with the AMPLATZER Cardiac Plug

EuroIntervention

Volumn 11, Issue 10, 2016, Pages 1170-1179

  Tzikas, Apostolos ^a,b   Shakir, Samera ^c   Gafoor, Sameer ^d   Omran, Heyder ^e   Berti, Sergio ^f   Santoro, Gennaro ^g   Kefer, Joelle ^h   Landmesser, Ulf ⁱ   Nielsen Kudsk, Jens Erik ^j   Cruz Gonzalez, Ignacio ^k   Sievert, Horst ^d   Tichelbäcker, Tobias ^l   Kanagaratnam, Prapa ^m   Nietlispach, Fabian ^c,i   Aminian, Adel ⁿ   Kasch, Friederike ^o   Freixa, Xavier ^p,q   Danna, Paolo ^r   Rezzaghi, Marco ^f   Vermeersch, Paul ^s   Stock, Friederike ^e   Stolcova, Miroslava ^g   Costa, Marco ^t   Ibrahim, Reda ^q   Schillinger, Wolfgang ^l   Meier, Bernhard ^c   Park, Jai Wun ^o   more..

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

^b INTERBALKAN MEDICAL CENTER   (Greece)

^c UNIVERSITY OF BERN   (Switzerland)

^d CardioVascular Center Frankfurt   (Germany)

^e UNIVERSITY HOSPITAL BONN   (Germany)

^f Fondazione Toscana Gabriele Monasterio   (Italy)

^g CAREGGI UNIVERSITY HOSPITAL   (Italy)

^h CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

ⁱ UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^j AARHUS UNIVERSITY HOSPITAL   (Denmark)

^k HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^l UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^m IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

ⁿ Centre Hospitalier Universitaire de Charleroi   (Belgium)

^o Asklepios Hospital Hamburg   (Germany)

^p UNIVERSITY OF BARCELONA   (Spain)

^q MONTREAL HEART INSTITUTE   (Canada)

^r UNIVERSITY OF MILAN   (Italy)

^s MIDDELHEIM HOSPITAL   (Belgium)

^t CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

more..

Author keywords

Appendage closure; Bleeding; Left atrial; Stroke risk

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; LOW MOLECULAR WEIGHT HEPARIN; PHENPROCOUMON; WARFARIN;

ABSENCE OF COMPLICATIONS; AGED; AIR EMBOLISM; ALTERNATIVE MEDICINE; AMPLATZER VASCULAR PLUG; ARTERIOVENOUS FISTULA; ARTERY PERFORATION; ARTICLE; ATRIAL FIBRILLATION; BLEEDING; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEATH; DEVICE EMBOLIZATION; DEVICE RELATED THROMBUS; FALSE ANEURYSM; FEASIBILITY STUDY; FEMALE; FEMORAL ARTERY BLEEDING; FEMORAL ARTERY PSEUDOANEURYSM; FOLLOW UP; HEART ARRHYTHMIA; HEART INFARCTION; HEART TAMPONADE; HUMAN; LEFT ATRIAL APPENDAGE OCCLUSION; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MONOTHERAPY; MORTALITY RATE; MULTICENTER STUDY; PATIENT SAFETY; PNEUMONIA; PROSPECTIVE STUDY; PULMONARY ARTERY PERFORATION; RISK REDUCTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBOEMBOLISM; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; TREATMENT RESPONSE; ADVERSE EFFECTS; CLINICAL TRIAL; HEART ATRIUM APPENDAGE; HEART CATHETERIZATION; PROCEDURES; SEPTAL OCCLUDER; STROKE; SURGERY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; CARDIAC CATHETERIZATION; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HUMANS; MALE; SEPTAL OCCLUDER DEVICE; STROKE; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 85016468182     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJY15M01_06     Document Type: Article

References (19)

1. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P; PROTECT AF Investigators. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374: 534-42.
2. Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation. 2011;123:417-24.
3. Holmes DR Jr, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, Huber K, Reddy VY. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64:1-12.
4. Reddy VY, Sievert H, Halperin J, Doshi SK, Buchbinder M, Neuzil P, Huber K, Whisenant B, Kar S, Swarup V, Gordon N, Holmes D; PROTECT AF Steering Committee and Investigators. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. JAMA. 2014;312:1988-98.
5. Park JW, Bethencourt A, Sievert H, Santoro G, Meier B, Walsh K, Lopez-Minguez JR, Meerkin D, Valdés M, Ormerod O, Leithäuser B. Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience. Catheter Cardiovasc Interv. 2011;77:700-6.
6. Urena M, Rodés-Cabau J, Freixa X, Saw J, Webb JG, Freeman M, Horlick E, Osten M, Chan A, Marquis JF, Champagne J, Ibrahim R. Percutaneous left atrial appendage closure with the AMPLATZER cardiac plug device in patients with non-valvular atrial fibrillation and contraindications for anticoagulation therapy. J Am Coll Cardiol. 2013;62:96-102.
7. Meerkin D, Butnaru A, Dratva D, Bertrand OF, Tzivoni D. Early safety of the Amplatzer Cardiac Plug™ for left atrial appendage occlusion. Int J Cardiol. 2013;168:3920-5.
8. Nietlispach F, Gloekler S, Krause R, Shakir S, Schmid M, Khattab AA, Wenaweser P, Windecker S, Meier B. Amplatzer left atrial appendage occlusion: single center 10-year experience. Catheter Cardiovasc Interv. 2013;82:283-9.
9. Bartus K, Han FT, Bednarek J, Myc J, Kapelak B, Sadowski J, Lelakowski J, Bartus S, Yakubov SJ, Lee RJ. Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. J Am Coll Cardiol. 2013;62:108-18.
10. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P; ESC Committee for Practice Guidelines (CPG). 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33:2719-47.
11. Kappetein AP, Head SJ, Généreux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodés-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol. 2012;60:1438-54.
12. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137:263-72.
13. Lip GY, Frison L, Halperin JL, Lane DA. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score. J Am Coll Cardiol. 2011;57:173-80.
14. Viles-Gonzalez JF, Kar S, Douglas P, Dukkipati S, Feldman T, Horton R, Holmes D, Reddy VY. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy. J Am Coll Cardiol. 2012;59:923-9.
15. Freixa X, Tzikas A, Sobrino A, Chan J, Basmadjian AJ, Ibrahim R. Left atrial appendage closure with the Amplatzer™ Cardiac Plug: impact of shape and device sizing on follow-up leaks. Int J Cardiol. 2013;168:1023-7.
16. Kanderian AS, Gillinov AM, Pettersson GB, Blackstone E, Klein AL. Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography. J Am Coll Cardiol. 2008;52:924-9.
17. Kirley K, Qato DM, Kornfield R, Stafford RS, Alexander GC. National trends in oral anticoagulant use in the United States, 2007 to 2011. Circ Cardiovasc Qual Outcomes. 2012;5:615-21.
18. Tzikas A, Freixa X, Ibrahim R. Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: ready for the prime time? Expert Rev Cardiovasc Ther. 2013;11:1587-9.
19. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857-67.